Third Proxy Firm Favors Re-election of Illumina Board Members over Roche Candidates | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A third proxy advisory firm has recommended that Illumina shareholders re-elect all four members of its board who up for re-election at the firm's annual shareholders meeting next week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.